GUCA1C: A Potential Drug Target and Biomarker (G9626)
GUCA1C: A Potential Drug Target and Biomarker
Guanylate cyclase activator 1C (GUCA1C) is a protein that plays a crucial role in cellular signaling. It is a key enzyme in the guanylate cyclase signaling pathway, which is involved in the regulation of various cellular processes, including cell signaling, cell cycle progression, and protein synthesis. GUCA1C is highly expressed in various tissues and cells, including the heart, skeletal muscles, and brain.
GUCA1C is a potential drug target because of its involvement in various cellular processes that are crucial for human health. It is involved in the regulation of cell signaling, which is critical for the development and maintenance of tissues and organs. When signaling pathways are disrupted, GUCA1C is implicated in the development of various diseases, including heart disease, cancer, and neurological disorders.
GUCA1C is also a potential biomarker for various diseases. The levels of GUCA1C are often elevated in the tissues and cells affected by these diseases, which can be used as a diagnostic or predictive tool. For example, increased levels of GUCA1C have been observed in the hearts of patients with heart failure, which suggests that GUCA1C may be a useful biomarker for this disease. Similarly, the levels of GUCA1C have been found to be elevated in the brains of patients with Alzheimer's disease, which may make GUCA1C a useful biomarker for this disease.
GUCA1C is a protein that is expressed in various tissues and cells, including the heart, skeletal muscles, and brain. It is involved in the regulation of cellular signaling and is a potential drug target and biomarker for various diseases.
The guanylate cyclase signaling pathway is a critical pathway involved in the regulation of various cellular processes. It is a complex signaling pathway that involves the interaction of multiple proteins, including GUCA1C. This pathway is involved in the regulation of cell signaling, which is critical for the development and maintenance of tissues and organs.
GUCA1C is a key enzyme in the guanylate cyclase signaling pathway. It is a small, transmembrane protein that is expressed in various tissues and cells, including the heart, skeletal muscles, and brain. GUCA1C is involved in the regulation of cellular signaling by activating the activity of other proteins, including cyclic AMP-dependent protein kinases (Ca2+-ATP-dependent kinases).
GUCA1C is a critical enzyme for the regulation of cellular signaling in various tissues and cells. It is involved in the regulation of cell signaling by activating the activity of other proteins, including Ca2+-ATP-dependent protein kinases (Ca2+-ATP-dependent kinases). These proteins are involved in the regulation of various cellular processes, including cell signaling, cell cycle progression, and protein synthesis.
GUCA1C is a potential drug target because of its involvement in various cellular processes that are crucial for human health. It is involved in the regulation of cell signaling, which is critical for the development and maintenance of tissues and organs. When signaling pathways are disrupted, GUCA1C is implicated in the development of various diseases, including heart disease, cancer, and neurological disorders.
GUCA1C is also a potential biomarker for various diseases. The levels of GUCA1C are often elevated in the tissues and cells affected by these diseases, which can be used as a diagnostic or predictive tool. For example, increased levels of GUCA1C have been observed in the hearts of patients with heart failure, which suggests that GUCA1C may be a useful biomarker for this disease. Similarly, the levels of GUCA1C have been found to be elevated in the brains of patients with Alzheimer's disease, which may make GUCA1C a useful biomarker
Protein Name: Guanylate Cyclase Activator 1C
Functions: Stimulates guanylyl cyclase 1 (GC1) and GC2 when free calcium ions concentration is low and inhibits guanylyl cyclases when free calcium ions concentration is elevated. This Ca(2+)-sensitive regulation of guanylyl cyclase (GC) is a key event in recovery of the dark state of rod photoreceptors following light exposure
The "GUCA1C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GUCA1C comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GUCA2A | GUCA2B | GUCD1 | GUCY1A1 | GUCY1A2 | GUCY1B1 | GUCY1B2 | GUCY2C | GUCY2D | GUCY2EP | GUCY2F | GUCY2GP | GUF1 | GUK1 | GULOP | GULP1 | GUSB | GUSBP1 | GUSBP11 | GUSBP12 | GUSBP14 | GUSBP15 | GUSBP17 | GUSBP2 | GUSBP3 | GUSBP4 | GUSBP5 | GUSBP8 | GVINP1 | GVQW3 | GXYLT1 | GXYLT1P3 | GXYLT1P4 | GXYLT1P6 | GXYLT2 | GYG1 | GYG2 | GYPA | GYPB | GYPC | GYPE | GYS1 | GYS2 | GZF1 | GZMA | GZMB | GZMH | GZMK | GZMM | H1-0 | H1-1 | H1-10 | H1-10-AS1 | H1-2 | H1-3 | H1-4 | H1-5 | H1-6 | H1-7 | H1-8 | H1-9P | H19 | H19-ICR | H2AB1 | H2AB2 | H2AB3 | H2AC1 | H2AC11 | H2AC12 | H2AC13 | H2AC14 | H2AC15 | H2AC16 | H2AC17 | H2AC18 | H2AC20 | H2AC21 | H2AC25 | H2AC3P | H2AC4 | H2AC6 | H2AC7 | H2AJ | H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18
